P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA

Detalles Bibliográficos
Autores principales: Harikrishnan, P, Yanamandra, Uday, Muthukrishnan, J, Aggarwal, Deeptika, Yadav, Arun, Singh, Sk, Khurana, Harshit, Verghese, Renjith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429967/
http://dx.doi.org/10.1097/01.HS9.0000972860.64685.8e
_version_ 1785090843142520832
author Harikrishnan, P
Yanamandra, Uday
Muthukrishnan, J
Aggarwal, Deeptika
Yadav, Arun
Singh, Sk
Khurana, Harshit
Verghese, Renjith
author_facet Harikrishnan, P
Yanamandra, Uday
Muthukrishnan, J
Aggarwal, Deeptika
Yadav, Arun
Singh, Sk
Khurana, Harshit
Verghese, Renjith
author_sort Harikrishnan, P
collection PubMed
description
format Online
Article
Text
id pubmed-10429967
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104299672023-08-17 P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA Harikrishnan, P Yanamandra, Uday Muthukrishnan, J Aggarwal, Deeptika Yadav, Arun Singh, Sk Khurana, Harshit Verghese, Renjith Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429967/ http://dx.doi.org/10.1097/01.HS9.0000972860.64685.8e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Harikrishnan, P
Yanamandra, Uday
Muthukrishnan, J
Aggarwal, Deeptika
Yadav, Arun
Singh, Sk
Khurana, Harshit
Verghese, Renjith
P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
title P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
title_full P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
title_fullStr P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
title_full_unstemmed P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
title_short P1495: A PHASE III, RANDOMISED CONTROLLED SAFETY, EFFICACY AND COST EFFECTIVENESS TRIAL OF INTRAVENOUS IRON ISOMALTOSIDE (I3R) AND FERRIC CARBOXY MALTOSE (FERIUMR) IN SUBJECTS WITH IRON DEFICIENCY ANEMIA
title_sort p1495: a phase iii, randomised controlled safety, efficacy and cost effectiveness trial of intravenous iron isomaltoside (i3r) and ferric carboxy maltose (feriumr) in subjects with iron deficiency anemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429967/
http://dx.doi.org/10.1097/01.HS9.0000972860.64685.8e
work_keys_str_mv AT harikrishnanp p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia
AT yanamandrauday p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia
AT muthukrishnanj p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia
AT aggarwaldeeptika p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia
AT yadavarun p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia
AT singhsk p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia
AT khuranaharshit p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia
AT vergheserenjith p1495aphaseiiirandomisedcontrolledsafetyefficacyandcosteffectivenesstrialofintravenousironisomaltosidei3randferriccarboxymaltoseferiumrinsubjectswithirondeficiencyanemia

Ejemplares similares